fbpx
Accelerator

Here are the 12 deep tech startups CSIRO chose for its latest ON Accelerate program

- December 7, 2023 3 MIN READ
Automated Policy Management System
Automated Policy Management System (APMS) team from ANU
Science agency CSIRO has announced the 12 planned deep-tech startups selected for its ON Accelerate program in 2024.

The ideas span everything from global health challenges to sustainability through circularity, and advanced manufacturing.

The ON program gives university researchers access to a network of industry experts and investors, to help them refine and validate their ideas for commercial success, secure funding and build a company.

This is the 8th edition of the three-month program will kick off in February next year. Two thirds of the teams involved include women as cofounders.

Jessie Technology

The Jessie Technology team from the Australian Catholic University

CSIRO CEO, Doug Hilton said since its launch in 2015, ON alumni have formed 70 new companies, employed more than 600 people and raised more than $311 million in capital.

“ON Accelerate is about creating national benefits for Australia by giving researchers the skills they need to navigate their ideas along the often-fraught road between the lab and the market,” he said.

“Research commercialisation, science entrepreneurship and technical collaboration are all critical skills for Australia’s future and the ON program is equipping the next generation of innovators with the skills they need to make a difference for our future.”

The 12 teams are:

  • Jessie Technology, from the Australian Catholic University and supported by Microsoft, has developed an autonomous data entry technology that enhances the quality of care for aged care residents by reducing the time needed for workers to input data and compliance documentation while also enhancing workforce retention and meeting aged care provider compliant requirements.
  • Automated Policy Management Systems (APMS), supported by the Australian National University, simplifies the security accreditation process for SMEs entering the Defence Industry by mapping relationships between security documents, streamlining DISP (Defence Industry Security Program) applications, and supporting ongoing compliance.
  • ErythroSight, also from the Australian National University, is tackling a major challenge in treating retinal diseases, such as age-related macular degeneration, by developing a novel therapeutic from patients’ own red blood cells.
  • AquaTone Solutions, hailing from Griffith University, is harnessing the convergence of life sciences and machine learning to pioneer intelligent prawn farm management and deliver timely alerts to stakeholders on a local and global scale.
  • Infinite Bioworks, from James Cook University, is a startup specialising in advanced starter cells to fuel the future bio-revolution. The team’s goal is to partner with customers to develop advanced materials and ingredients that positively impact the planet.
  • RestorTOL, from Monash University, has developed an immune tolerance platform that identifies disease-causing epitopes and immune cell receptors in healthy humans. The technology can be used to create therapeutics such as vaccines and cell-based therapies for incurable diseases.
  • Originating out of the University of Newcastle, Wild Yeast Zoo’s technology leverages native yeast strains from Australia’s diverse ecosystems, isolating and characterising them to unlock novel pathways for industries like brewing, baking, pharmaceuticals, and biofuels.
  • Plasmid Therapy is a joint effort team from The Westmead Institute for Medical Research and The University of Sydney. The team is working on a technology that addresses the global threat of antimicrobial-resistant (AMR) infections. Removing AMR genes from bacteria and keeping them out with an affordable and safe oral solution makes common treatments safer and more effective.
  • Environmental Measurement Unit Systems or EMUS, from The University of Sydney deliver advanced heat stress management systems for athletes that in real-time optimises performance and keeps players safe.
  • From the University of Western Australia and partners, Cytophenix’s patented technology is an AI-boosted antimicrobial susceptibility test (AST), delivering clinically actionable evidence of antibiotic effectiveness in 3-5 hours, compared to the current 2-5 days.
  • CSIRO’s Mycena Biochemicals team has developed a novel manufacturing technology that is more versatile, productive, and sustainable than conventional bioreactor fermentation systems. It has the potential to make bioproducts more accessible and enable new products to come to market.
  • Continuous3D, another team from CSIRO, offers a fully automated solution for efficiently repairing critical metal components using sensors and advanced algorithms, significantly reducing robot program development time from weeks to minutes.